Position in XNCR
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$16,279,014
+$662,679 QoQ
Shares Held
1,011,119
-21.9% QoQ
Ownership
1.36%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 208 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 84%
Shared 9%
None 7%
Common Shares in XNCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. XNCR ranks #62 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in XNCR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,279,014 | 1,011,119 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $15,616,335 | 1,294,887 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $19,126,597 | 1,249,288 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $18,638,534 | 1,588,963 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $13,995,278 | 1,780,570 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $18,485,807 | 1,737,388 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $34,505,202 | 1,501,532 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $28,138,614 | 1,399,235 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $27,626,950 | 1,459,427 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $30,350,142 | 1,371,448 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $27,154,802 | 1,279,077 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $29,244,640 | 1,451,347 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $39,408,799 | 1,578,246 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $43,192,152 | 1,548,661 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $32,980,438 | 1,266,530 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $30,202,761 | 1,162,539 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $30,700,297 | 1,121,677 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $24,724,596 | 926,709 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $33,910,507 | 845,227 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $26,122,055 | 799,818 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $34,493,242 | 1,000,094 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $40,217,953 | 933,998 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $37,717,567 | 864,487 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $33,678,990 | 868,239 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $27,042,475 | 834,902 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $24,053,668 | 805,009 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||